Cargando…
Characterization and regulation of wild‐type and mutant TASK‐1 two pore domain potassium channels indicated in pulmonary arterial hypertension
KEY POINTS: The TASK‐1 channel gene (KCNK3) has been identified as a possible disease‐causing gene in heritable pulmonary arterial hypertension (PAH). In the present study, we show that novel mutated TASK‐1 channels, seen in PAH patients, have a substantially reduced current compared to wild‐type TA...
Autores principales: | Cunningham, Kevin P., Holden, Robyn G., Escribano‐Subias, Pilar M., Cogolludo, Angel, Veale, Emma L., Mathie, Alistair |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376074/ https://www.ncbi.nlm.nih.gov/pubmed/30365877 http://dx.doi.org/10.1113/JP277275 |
Ejemplares similares
-
Trafficking of Neuronal Two Pore Domain Potassium Channels
por: Mathie, Alistair, et al.
Publicado: (2010) -
Effects of the ventilatory stimulant, doxapram on human TASK‐3 (KCNK9, K2P9.1) channels and TASK‐1 (KCNK3, K2P3.1) channels
por: Cunningham, Kevin P., et al.
Publicado: (2019) -
The pungent substances piperine, capsaicin, 6-gingerol and polygodial inhibit the human two-pore domain potassium channels TASK-1, TASK-3 and TRESK
por: Beltrán, Leopoldo R., et al.
Publicado: (2013) -
The Prostacyclin Analogue, Treprostinil, Used in the Treatment of Pulmonary Arterial Hypertension, is a Potent Antagonist of TREK-1 and TREK-2 Potassium Channels
por: Cunningham, Kevin P., et al.
Publicado: (2021) -
A “Target Class” Screen to Identify Activators of Two-Pore Domain
Potassium (K2P) Channels
por: McCoull, David, et al.
Publicado: (2020)